Effects of medroxyprogesterone acetate (MPA) in activating progesterone receptor signaling in benign and cancer-associated fibroblasts of the endometrium
MedroxyprOgesterone acetate (MPA) is used for conservative treatment for endometrial cancer (EC); however, patients often develop progesterone resistance. Most typical and atypical endometrial hyperplasia shows regression after MPA treatment Primary type 1 .EC responds moderately to MFA therapy (5...
Saved in:
Main Authors: | Chung, I., Omar, I.S., Adenan, N.A., Woo, Y.L. |
---|---|
Format: | Conference or Workshop Item |
Language: | English |
Published: |
2017
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/18412/1/All.pdf http://eprints.um.edu.my/18412/ http://dx.doi.org/10.4172/1948-5956-C1-117 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Aberrant upregulation of CDK1 contributes to medroxyprogesterone acetate (MPA) resistance in cancer-associated fibroblasts of the endometrium
by: Omar, Intan Sofia, et al.
Published: (2022) -
MPA alters metabolic phenotype of endometrial cancer-associated fibroblasts from obese women via IRS2 signaling
by: Omar, Intan Sofia, et al.
Published: (2022) -
Cancer-Associated Fibroblasts Promote Proliferation of Endometrial Cancer Cells
by: Subramaniam, K.S., et al.
Published: (2013) -
Elevated expression of CD151 gene in estrogen receptor and progesterone receptor positive breast carcinoma
by: Ivyna Bong PN,, et al.
Published: (2011) -
Medroxyprogesterone acetate attenuates demyelination, modulating microglia activation in a cuprizone neurotoxic demyelinating mouse model
by: Mohammadi, Maryam, et al.
Published: (2021)